China stocks slip as healthcare firms retreat; Hong Kong up

Reuters2021-06-24

* SSEC -0.2%, CSI300 -0.2%, HSI 0.1%

* HK->Shanghai Connect daily quota used 4.4%, Shanghai->HK daily quota used 2.2%

* FTSE China A50 -0.1%

SHANGHAI, May 28 (Reuters) - China shares ticked lower on Thursday, dragged down by losses in the healthcare sector as drugmakers retreated on concerns over a plunge in medicine prices.

** The CSI300 index fell 0.2% to 5,137.37 points at the end of the morning session, while the Shanghai Composite Index lost 0.2% to 3,561.01 points.

** Leading the declines, the CSI300 healthcare index slumped 2.6% by the midday break after price slumps were shown in the results of the fifth national government-backed drug bulk-buy program.

** Hengrui , Guangzhou Kingmed Diagnostics Group Co Ltd , Asymchem Laboratories Tianjin Co Ltd, Bloomage Biotechnology Corp Ltd declined between 4.1% and 6.8%.

** Average price cut was 56% among the 251 products for 61 types of medicines included in the list of preliminary bid winners, state news agency Xinhua said in a report.

** Investors need to pay more attention to drugmakers' overall strength given a normalised bulk-buy mechanism, TF Securities said in a report, adding that bigger-than-expected price declines would be a risk for firms going forward.

** China's monthly producer price index (PPI) is likely to rise 10% in June, piling pressure on downstream consumers, a senior official of China's banking and insurance watchdog told a forum in Beijing on Thursday.

** On Wednesday, two Federal Reserve officials said a period of high inflation in the United States could last longer than anticipated, just a day after Fed Chair Jerome Powell played down rising price pressures.

** The Biden administration ordered a ban on U.S. imports of a key solar panel material from Chinese-based Hoshine Silicon Industry Co over forced labour allegations, said two sources briefed on the matter.

** Hoshine Silicon tumbled 9.9% after the U.S. ban.

** The Hang Seng index added 0.1% to 28,838.96 points, while the Hong Kong China Enterprises Index gained 0.1%, to 10,679.86.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

fardol
2021-06-24
fardol
what happened..
Supertooth
2021-06-24
Supertooth
Buy and like
w3tan
2021-06-24
w3tan
Interesting
TheHaq
2021-06-24
TheHaq
Interesting outlook
Bmaiw102
2021-06-24
Bmaiw102
Ouch
angelA
2021-06-24
angelA
Like n comment pls
- sleepymoon:
  Can
- csyen:
  can

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2145012162?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-06-24 12:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2145012162","market":"sh","top_or_hot":-1,"title":"China stocks slip as healthcare firms retreat; Hong Kong up","media":"Reuters","content":"<p>* SSEC -0.2%, CSI300 -0.2%, HSI 0.1%</p>\n<p>* HK-&gt;Shanghai Connect daily quota used 4.4%, Shanghai-&gt;HK daily quota used 2.2%</p>\n<p>* FTSE China A50 -0.1%</p>\n<p>SHANGHAI, May 28 (Reuters) - China shares ticked lower on Thursday, dragged down by losses in the healthcare sector as drugmakers retreated on concerns over a plunge in medicine prices.</p>\n<p>** The CSI300 index fell 0.2% to 5,137.37 points at the end of the morning session, while the Shanghai Composite Index lost 0.2% to 3,561.01 points.</p>\n<p>** Leading the declines, the CSI300 healthcare index&nbsp;slumped 2.6% by the midday break after price slumps were shown in the results of the fifth national government-backed drug bulk-buy program.</p>\n<p>** Hengrui , Guangzhou Kingmed Diagnostics Group Co Ltd , Asymchem Laboratories Tianjin Co Ltd, Bloomage Biotechnology Corp Ltd declined between 4.1% and 6.8%.</p>\n<p>** Average price cut was 56% among the 251 products for 61 types of medicines included in the list of preliminary bid winners, state news agency Xinhua said in a report.</p>\n<p>** Investors need to pay more attention to drugmakers' overall strength given a normalised bulk-buy mechanism, TF Securities said in a report, adding that bigger-than-expected price declines would be a risk for firms going forward.</p>\n<p>** China's monthly producer price index (PPI) is likely to rise 10% in June, piling pressure on downstream consumers, a senior official of China's banking and insurance watchdog told a forum in Beijing on Thursday.</p>\n<p>** On Wednesday, two Federal Reserve officials said a period of high inflation in the United States could last longer than anticipated, just a day after Fed Chair Jerome Powell played down rising price pressures.</p>\n<p>** The Biden administration ordered a ban on U.S. imports of a key solar panel material from Chinese-based Hoshine Silicon Industry Co over forced labour allegations, said two sources briefed on the matter.</p>\n<p>** Hoshine Silicon tumbled 9.9% after the U.S. ban.</p>\n<p>** The Hang Seng index&nbsp;added 0.1% to 28,838.96 points, while the Hong Kong China Enterprises Index&nbsp;gained 0.1%, to 10,679.86.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China stocks slip as healthcare firms retreat; Hong Kong up</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina stocks slip as healthcare firms retreat; Hong Kong up\n</h2>\n\n<h4 class=\"meta\">\n\n2021-06-24 12:31 北京时间&nbsp;&nbsp;&nbsp;<strong>Reuters</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>* SSEC -0.2%, CSI300 -0.2%, HSI 0.1%\n* HK->Shanghai Connect daily quota used 4.4%, Shanghai->HK daily quota used 2.2%\n* FTSE China A50 -0.1%\nSHANGHAI, May 28 (Reuters) - China shares ticked lower on ...</p>\n\n<a href=\"None\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"000001.SH","symbol_name":"上证指数","start_time":0,"source_url":null,"article_id":"2145012162","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2145012162","pubTimestamp":1624509077,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"* SSEC -0.2%, CSI300 -0.2%, HSI 0.1%\n* HK->Shanghai Connect daily quota used 4.4%, Shanghai->HK dail","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"000001.SH":"上证指数","HSI":"恒生指数"},"translate_title":"随着医疗保健公司的撤退，中国股市下跌；香港up","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"000001.SH":0.9,"HSI":0.9},"content_text":"* SSEC -0.2%, CSI300 -0.2%, HSI 0.1%\n* HK->Shanghai Connect daily quota used 4.4%, Shanghai->HK daily quota used 2.2%\n* FTSE China A50 -0.1%\nSHANGHAI, May 28 (Reuters) - China shares ticked lower on Thursday, dragged down by losses in the healthcare sector as drugmakers retreated on concerns over a plunge in medicine prices.\n** The CSI300 index fell 0.2% to 5,137.37 points at the end of the morning session, while the Shanghai Composite Index lost 0.2% to 3,561.01 points.\n** Leading the declines, the CSI300 healthcare index slumped 2.6% by the midday break after price slumps were shown in the results of the fifth national government-backed drug bulk-buy program.\n** Hengrui , Guangzhou Kingmed Diagnostics Group Co Ltd , Asymchem Laboratories Tianjin Co Ltd, Bloomage Biotechnology Corp Ltd declined between 4.1% and 6.8%.\n** Average price cut was 56% among the 251 products for 61 types of medicines included in the list of preliminary bid winners, state news agency Xinhua said in a report.\n** Investors need to pay more attention to drugmakers' overall strength given a normalised bulk-buy mechanism, TF Securities said in a report, adding that bigger-than-expected price declines would be a risk for firms going forward.\n** China's monthly producer price index (PPI) is likely to rise 10% in June, piling pressure on downstream consumers, a senior official of China's banking and insurance watchdog told a forum in Beijing on Thursday.\n** On Wednesday, two Federal Reserve officials said a period of high inflation in the United States could last longer than anticipated, just a day after Fed Chair Jerome Powell played down rising price pressures.\n** The Biden administration ordered a ban on U.S. imports of a key solar panel material from Chinese-based Hoshine Silicon Industry Co over forced labour allegations, said two sources briefed on the matter.\n** Hoshine Silicon tumbled 9.9% after the U.S. ban.\n** The Hang Seng index added 0.1% to 28,838.96 points, while the Hong Kong China Enterprises Index gained 0.1%, to 10,679.86.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":128683590,"gmtCreate":1624513646610,"gmtModify":1703838973600,"author":{"id":"3584730287449042","authorId":"3584730287449042","name":"fardol","avatar":"https://static.tigerbbs.com/addeb364052adeb2a9475a2753046107","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3584730287449042","authorIdStr":"3584730287449042"},"htmlText":"what happened..&nbsp;","listText":"what happened..&nbsp;","text":"what happened..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/128683590","repostId":2145012162,"repostType":4,"repost":{"id":"2145012162","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1624509077,"share":"https://ttm.financial/m/news/2145012162?lang=&edition=fundamental","pubTime":"2021-06-24 12:31","market":"hk","language":"en","title":"China stocks slip as healthcare firms retreat; Hong Kong up","url":"https://stock-news.laohu8.com/highlight/detail?id=2145012162","media":"Reuters","summary":"* SSEC -0.2%, CSI300 -0.2%, HSI 0.1%\n* HK->Shanghai Connect daily quota used 4.4%, Shanghai->HK dail","content":"<p>* SSEC -0.2%, CSI300 -0.2%, HSI 0.1%</p>\n<p>* HK-&gt;Shanghai Connect daily quota used 4.4%, Shanghai-&gt;HK daily quota used 2.2%</p>\n<p>* FTSE China A50 -0.1%</p>\n<p>SHANGHAI, May 28 (Reuters) - China shares ticked lower on Thursday, dragged down by losses in the healthcare sector as drugmakers retreated on concerns over a plunge in medicine prices.</p>\n<p>** The CSI300 index fell 0.2% to 5,137.37 points at the end of the morning session, while the Shanghai Composite Index lost 0.2% to 3,561.01 points.</p>\n<p>** Leading the declines, the CSI300 healthcare index&nbsp;slumped 2.6% by the midday break after price slumps were shown in the results of the fifth national government-backed drug bulk-buy program.</p>\n<p>** Hengrui , Guangzhou Kingmed Diagnostics Group Co Ltd , Asymchem Laboratories Tianjin Co Ltd, Bloomage Biotechnology Corp Ltd declined between 4.1% and 6.8%.</p>\n<p>** Average price cut was 56% among the 251 products for 61 types of medicines included in the list of preliminary bid winners, state news agency Xinhua said in a report.</p>\n<p>** Investors need to pay more attention to drugmakers' overall strength given a normalised bulk-buy mechanism, TF Securities said in a report, adding that bigger-than-expected price declines would be a risk for firms going forward.</p>\n<p>** China's monthly producer price index (PPI) is likely to rise 10% in June, piling pressure on downstream consumers, a senior official of China's banking and insurance watchdog told a forum in Beijing on Thursday.</p>\n<p>** On Wednesday, two Federal Reserve officials said a period of high inflation in the United States could last longer than anticipated, just a day after Fed Chair Jerome Powell played down rising price pressures.</p>\n<p>** The Biden administration ordered a ban on U.S. imports of a key solar panel material from Chinese-based Hoshine Silicon Industry Co over forced labour allegations, said two sources briefed on the matter.</p>\n<p>** Hoshine Silicon tumbled 9.9% after the U.S. ban.</p>\n<p>** The Hang Seng index&nbsp;added 0.1% to 28,838.96 points, while the Hong Kong China Enterprises Index&nbsp;gained 0.1%, to 10,679.86.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China stocks slip as healthcare firms retreat; Hong Kong up</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina stocks slip as healthcare firms retreat; Hong Kong up\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-24 12:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* SSEC -0.2%, CSI300 -0.2%, HSI 0.1%</p>\n<p>* HK-&gt;Shanghai Connect daily quota used 4.4%, Shanghai-&gt;HK daily quota used 2.2%</p>\n<p>* FTSE China A50 -0.1%</p>\n<p>SHANGHAI, May 28 (Reuters) - China shares ticked lower on Thursday, dragged down by losses in the healthcare sector as drugmakers retreated on concerns over a plunge in medicine prices.</p>\n<p>** The CSI300 index fell 0.2% to 5,137.37 points at the end of the morning session, while the Shanghai Composite Index lost 0.2% to 3,561.01 points.</p>\n<p>** Leading the declines, the CSI300 healthcare index&nbsp;slumped 2.6% by the midday break after price slumps were shown in the results of the fifth national government-backed drug bulk-buy program.</p>\n<p>** Hengrui , Guangzhou Kingmed Diagnostics Group Co Ltd , Asymchem Laboratories Tianjin Co Ltd, Bloomage Biotechnology Corp Ltd declined between 4.1% and 6.8%.</p>\n<p>** Average price cut was 56% among the 251 products for 61 types of medicines included in the list of preliminary bid winners, state news agency Xinhua said in a report.</p>\n<p>** Investors need to pay more attention to drugmakers' overall strength given a normalised bulk-buy mechanism, TF Securities said in a report, adding that bigger-than-expected price declines would be a risk for firms going forward.</p>\n<p>** China's monthly producer price index (PPI) is likely to rise 10% in June, piling pressure on downstream consumers, a senior official of China's banking and insurance watchdog told a forum in Beijing on Thursday.</p>\n<p>** On Wednesday, two Federal Reserve officials said a period of high inflation in the United States could last longer than anticipated, just a day after Fed Chair Jerome Powell played down rising price pressures.</p>\n<p>** The Biden administration ordered a ban on U.S. imports of a key solar panel material from Chinese-based Hoshine Silicon Industry Co over forced labour allegations, said two sources briefed on the matter.</p>\n<p>** Hoshine Silicon tumbled 9.9% after the U.S. ban.</p>\n<p>** The Hang Seng index&nbsp;added 0.1% to 28,838.96 points, while the Hong Kong China Enterprises Index&nbsp;gained 0.1%, to 10,679.86.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"000001.SH":"上证指数","HSI":"恒生指数"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2145012162","content_text":"* SSEC -0.2%, CSI300 -0.2%, HSI 0.1%\n* HK->Shanghai Connect daily quota used 4.4%, Shanghai->HK daily quota used 2.2%\n* FTSE China A50 -0.1%\nSHANGHAI, May 28 (Reuters) - China shares ticked lower on Thursday, dragged down by losses in the healthcare sector as drugmakers retreated on concerns over a plunge in medicine prices.\n** The CSI300 index fell 0.2% to 5,137.37 points at the end of the morning session, while the Shanghai Composite Index lost 0.2% to 3,561.01 points.\n** Leading the declines, the CSI300 healthcare index slumped 2.6% by the midday break after price slumps were shown in the results of the fifth national government-backed drug bulk-buy program.\n** Hengrui , Guangzhou Kingmed Diagnostics Group Co Ltd , Asymchem Laboratories Tianjin Co Ltd, Bloomage Biotechnology Corp Ltd declined between 4.1% and 6.8%.\n** Average price cut was 56% among the 251 products for 61 types of medicines included in the list of preliminary bid winners, state news agency Xinhua said in a report.\n** Investors need to pay more attention to drugmakers' overall strength given a normalised bulk-buy mechanism, TF Securities said in a report, adding that bigger-than-expected price declines would be a risk for firms going forward.\n** China's monthly producer price index (PPI) is likely to rise 10% in June, piling pressure on downstream consumers, a senior official of China's banking and insurance watchdog told a forum in Beijing on Thursday.\n** On Wednesday, two Federal Reserve officials said a period of high inflation in the United States could last longer than anticipated, just a day after Fed Chair Jerome Powell played down rising price pressures.\n** The Biden administration ordered a ban on U.S. imports of a key solar panel material from Chinese-based Hoshine Silicon Industry Co over forced labour allegations, said two sources briefed on the matter.\n** Hoshine Silicon tumbled 9.9% after the U.S. ban.\n** The Hang Seng index added 0.1% to 28,838.96 points, while the Hong Kong China Enterprises Index gained 0.1%, to 10,679.86.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":128636412,"gmtCreate":1624512986236,"gmtModify":1703838949747,"author":{"id":"3569374301908252","authorId":"3569374301908252","name":"Supertooth","avatar":"https://static.tigerbbs.com/61f9dd5a09490dcc3db856532e674755","vip":1,"crmLevel":3,"crmLevelSwitch":1,"idStr":"3569374301908252","authorIdStr":"3569374301908252"},"htmlText":"Buy and like","listText":"Buy and like","text":"Buy and like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/128636412","repostId":2145012162,"repostType":4,"repost":{"id":"2145012162","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1624509077,"share":"https://ttm.financial/m/news/2145012162?lang=&edition=fundamental","pubTime":"2021-06-24 12:31","market":"hk","language":"en","title":"China stocks slip as healthcare firms retreat; Hong Kong up","url":"https://stock-news.laohu8.com/highlight/detail?id=2145012162","media":"Reuters","summary":"* SSEC -0.2%, CSI300 -0.2%, HSI 0.1%\n* HK->Shanghai Connect daily quota used 4.4%, Shanghai->HK dail","content":"<p>* SSEC -0.2%, CSI300 -0.2%, HSI 0.1%</p>\n<p>* HK-&gt;Shanghai Connect daily quota used 4.4%, Shanghai-&gt;HK daily quota used 2.2%</p>\n<p>* FTSE China A50 -0.1%</p>\n<p>SHANGHAI, May 28 (Reuters) - China shares ticked lower on Thursday, dragged down by losses in the healthcare sector as drugmakers retreated on concerns over a plunge in medicine prices.</p>\n<p>** The CSI300 index fell 0.2% to 5,137.37 points at the end of the morning session, while the Shanghai Composite Index lost 0.2% to 3,561.01 points.</p>\n<p>** Leading the declines, the CSI300 healthcare index&nbsp;slumped 2.6% by the midday break after price slumps were shown in the results of the fifth national government-backed drug bulk-buy program.</p>\n<p>** Hengrui , Guangzhou Kingmed Diagnostics Group Co Ltd , Asymchem Laboratories Tianjin Co Ltd, Bloomage Biotechnology Corp Ltd declined between 4.1% and 6.8%.</p>\n<p>** Average price cut was 56% among the 251 products for 61 types of medicines included in the list of preliminary bid winners, state news agency Xinhua said in a report.</p>\n<p>** Investors need to pay more attention to drugmakers' overall strength given a normalised bulk-buy mechanism, TF Securities said in a report, adding that bigger-than-expected price declines would be a risk for firms going forward.</p>\n<p>** China's monthly producer price index (PPI) is likely to rise 10% in June, piling pressure on downstream consumers, a senior official of China's banking and insurance watchdog told a forum in Beijing on Thursday.</p>\n<p>** On Wednesday, two Federal Reserve officials said a period of high inflation in the United States could last longer than anticipated, just a day after Fed Chair Jerome Powell played down rising price pressures.</p>\n<p>** The Biden administration ordered a ban on U.S. imports of a key solar panel material from Chinese-based Hoshine Silicon Industry Co over forced labour allegations, said two sources briefed on the matter.</p>\n<p>** Hoshine Silicon tumbled 9.9% after the U.S. ban.</p>\n<p>** The Hang Seng index&nbsp;added 0.1% to 28,838.96 points, while the Hong Kong China Enterprises Index&nbsp;gained 0.1%, to 10,679.86.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China stocks slip as healthcare firms retreat; Hong Kong up</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina stocks slip as healthcare firms retreat; Hong Kong up\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-24 12:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* SSEC -0.2%, CSI300 -0.2%, HSI 0.1%</p>\n<p>* HK-&gt;Shanghai Connect daily quota used 4.4%, Shanghai-&gt;HK daily quota used 2.2%</p>\n<p>* FTSE China A50 -0.1%</p>\n<p>SHANGHAI, May 28 (Reuters) - China shares ticked lower on Thursday, dragged down by losses in the healthcare sector as drugmakers retreated on concerns over a plunge in medicine prices.</p>\n<p>** The CSI300 index fell 0.2% to 5,137.37 points at the end of the morning session, while the Shanghai Composite Index lost 0.2% to 3,561.01 points.</p>\n<p>** Leading the declines, the CSI300 healthcare index&nbsp;slumped 2.6% by the midday break after price slumps were shown in the results of the fifth national government-backed drug bulk-buy program.</p>\n<p>** Hengrui , Guangzhou Kingmed Diagnostics Group Co Ltd , Asymchem Laboratories Tianjin Co Ltd, Bloomage Biotechnology Corp Ltd declined between 4.1% and 6.8%.</p>\n<p>** Average price cut was 56% among the 251 products for 61 types of medicines included in the list of preliminary bid winners, state news agency Xinhua said in a report.</p>\n<p>** Investors need to pay more attention to drugmakers' overall strength given a normalised bulk-buy mechanism, TF Securities said in a report, adding that bigger-than-expected price declines would be a risk for firms going forward.</p>\n<p>** China's monthly producer price index (PPI) is likely to rise 10% in June, piling pressure on downstream consumers, a senior official of China's banking and insurance watchdog told a forum in Beijing on Thursday.</p>\n<p>** On Wednesday, two Federal Reserve officials said a period of high inflation in the United States could last longer than anticipated, just a day after Fed Chair Jerome Powell played down rising price pressures.</p>\n<p>** The Biden administration ordered a ban on U.S. imports of a key solar panel material from Chinese-based Hoshine Silicon Industry Co over forced labour allegations, said two sources briefed on the matter.</p>\n<p>** Hoshine Silicon tumbled 9.9% after the U.S. ban.</p>\n<p>** The Hang Seng index&nbsp;added 0.1% to 28,838.96 points, while the Hong Kong China Enterprises Index&nbsp;gained 0.1%, to 10,679.86.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"000001.SH":"上证指数","HSI":"恒生指数"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2145012162","content_text":"* SSEC -0.2%, CSI300 -0.2%, HSI 0.1%\n* HK->Shanghai Connect daily quota used 4.4%, Shanghai->HK daily quota used 2.2%\n* FTSE China A50 -0.1%\nSHANGHAI, May 28 (Reuters) - China shares ticked lower on Thursday, dragged down by losses in the healthcare sector as drugmakers retreated on concerns over a plunge in medicine prices.\n** The CSI300 index fell 0.2% to 5,137.37 points at the end of the morning session, while the Shanghai Composite Index lost 0.2% to 3,561.01 points.\n** Leading the declines, the CSI300 healthcare index slumped 2.6% by the midday break after price slumps were shown in the results of the fifth national government-backed drug bulk-buy program.\n** Hengrui , Guangzhou Kingmed Diagnostics Group Co Ltd , Asymchem Laboratories Tianjin Co Ltd, Bloomage Biotechnology Corp Ltd declined between 4.1% and 6.8%.\n** Average price cut was 56% among the 251 products for 61 types of medicines included in the list of preliminary bid winners, state news agency Xinhua said in a report.\n** Investors need to pay more attention to drugmakers' overall strength given a normalised bulk-buy mechanism, TF Securities said in a report, adding that bigger-than-expected price declines would be a risk for firms going forward.\n** China's monthly producer price index (PPI) is likely to rise 10% in June, piling pressure on downstream consumers, a senior official of China's banking and insurance watchdog told a forum in Beijing on Thursday.\n** On Wednesday, two Federal Reserve officials said a period of high inflation in the United States could last longer than anticipated, just a day after Fed Chair Jerome Powell played down rising price pressures.\n** The Biden administration ordered a ban on U.S. imports of a key solar panel material from Chinese-based Hoshine Silicon Industry Co over forced labour allegations, said two sources briefed on the matter.\n** Hoshine Silicon tumbled 9.9% after the U.S. ban.\n** The Hang Seng index added 0.1% to 28,838.96 points, while the Hong Kong China Enterprises Index gained 0.1%, to 10,679.86.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":128694952,"gmtCreate":1624512709076,"gmtModify":1703838939355,"author":{"id":"3580027277441703","authorId":"3580027277441703","name":"w3tan","avatar":"https://static.tigerbbs.com/924932717f7ac0e1c7cb8594ab4c810f","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3580027277441703","authorIdStr":"3580027277441703"},"htmlText":"Interesting","listText":"Interesting","text":"Interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/128694952","repostId":2145012162,"repostType":4,"repost":{"id":"2145012162","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1624509077,"share":"https://ttm.financial/m/news/2145012162?lang=&edition=fundamental","pubTime":"2021-06-24 12:31","market":"hk","language":"en","title":"China stocks slip as healthcare firms retreat; Hong Kong up","url":"https://stock-news.laohu8.com/highlight/detail?id=2145012162","media":"Reuters","summary":"* SSEC -0.2%, CSI300 -0.2%, HSI 0.1%\n* HK->Shanghai Connect daily quota used 4.4%, Shanghai->HK dail","content":"<p>* SSEC -0.2%, CSI300 -0.2%, HSI 0.1%</p>\n<p>* HK-&gt;Shanghai Connect daily quota used 4.4%, Shanghai-&gt;HK daily quota used 2.2%</p>\n<p>* FTSE China A50 -0.1%</p>\n<p>SHANGHAI, May 28 (Reuters) - China shares ticked lower on Thursday, dragged down by losses in the healthcare sector as drugmakers retreated on concerns over a plunge in medicine prices.</p>\n<p>** The CSI300 index fell 0.2% to 5,137.37 points at the end of the morning session, while the Shanghai Composite Index lost 0.2% to 3,561.01 points.</p>\n<p>** Leading the declines, the CSI300 healthcare index&nbsp;slumped 2.6% by the midday break after price slumps were shown in the results of the fifth national government-backed drug bulk-buy program.</p>\n<p>** Hengrui , Guangzhou Kingmed Diagnostics Group Co Ltd , Asymchem Laboratories Tianjin Co Ltd, Bloomage Biotechnology Corp Ltd declined between 4.1% and 6.8%.</p>\n<p>** Average price cut was 56% among the 251 products for 61 types of medicines included in the list of preliminary bid winners, state news agency Xinhua said in a report.</p>\n<p>** Investors need to pay more attention to drugmakers' overall strength given a normalised bulk-buy mechanism, TF Securities said in a report, adding that bigger-than-expected price declines would be a risk for firms going forward.</p>\n<p>** China's monthly producer price index (PPI) is likely to rise 10% in June, piling pressure on downstream consumers, a senior official of China's banking and insurance watchdog told a forum in Beijing on Thursday.</p>\n<p>** On Wednesday, two Federal Reserve officials said a period of high inflation in the United States could last longer than anticipated, just a day after Fed Chair Jerome Powell played down rising price pressures.</p>\n<p>** The Biden administration ordered a ban on U.S. imports of a key solar panel material from Chinese-based Hoshine Silicon Industry Co over forced labour allegations, said two sources briefed on the matter.</p>\n<p>** Hoshine Silicon tumbled 9.9% after the U.S. ban.</p>\n<p>** The Hang Seng index&nbsp;added 0.1% to 28,838.96 points, while the Hong Kong China Enterprises Index&nbsp;gained 0.1%, to 10,679.86.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China stocks slip as healthcare firms retreat; Hong Kong up</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina stocks slip as healthcare firms retreat; Hong Kong up\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-24 12:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* SSEC -0.2%, CSI300 -0.2%, HSI 0.1%</p>\n<p>* HK-&gt;Shanghai Connect daily quota used 4.4%, Shanghai-&gt;HK daily quota used 2.2%</p>\n<p>* FTSE China A50 -0.1%</p>\n<p>SHANGHAI, May 28 (Reuters) - China shares ticked lower on Thursday, dragged down by losses in the healthcare sector as drugmakers retreated on concerns over a plunge in medicine prices.</p>\n<p>** The CSI300 index fell 0.2% to 5,137.37 points at the end of the morning session, while the Shanghai Composite Index lost 0.2% to 3,561.01 points.</p>\n<p>** Leading the declines, the CSI300 healthcare index&nbsp;slumped 2.6% by the midday break after price slumps were shown in the results of the fifth national government-backed drug bulk-buy program.</p>\n<p>** Hengrui , Guangzhou Kingmed Diagnostics Group Co Ltd , Asymchem Laboratories Tianjin Co Ltd, Bloomage Biotechnology Corp Ltd declined between 4.1% and 6.8%.</p>\n<p>** Average price cut was 56% among the 251 products for 61 types of medicines included in the list of preliminary bid winners, state news agency Xinhua said in a report.</p>\n<p>** Investors need to pay more attention to drugmakers' overall strength given a normalised bulk-buy mechanism, TF Securities said in a report, adding that bigger-than-expected price declines would be a risk for firms going forward.</p>\n<p>** China's monthly producer price index (PPI) is likely to rise 10% in June, piling pressure on downstream consumers, a senior official of China's banking and insurance watchdog told a forum in Beijing on Thursday.</p>\n<p>** On Wednesday, two Federal Reserve officials said a period of high inflation in the United States could last longer than anticipated, just a day after Fed Chair Jerome Powell played down rising price pressures.</p>\n<p>** The Biden administration ordered a ban on U.S. imports of a key solar panel material from Chinese-based Hoshine Silicon Industry Co over forced labour allegations, said two sources briefed on the matter.</p>\n<p>** Hoshine Silicon tumbled 9.9% after the U.S. ban.</p>\n<p>** The Hang Seng index&nbsp;added 0.1% to 28,838.96 points, while the Hong Kong China Enterprises Index&nbsp;gained 0.1%, to 10,679.86.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"000001.SH":"上证指数","HSI":"恒生指数"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2145012162","content_text":"* SSEC -0.2%, CSI300 -0.2%, HSI 0.1%\n* HK->Shanghai Connect daily quota used 4.4%, Shanghai->HK daily quota used 2.2%\n* FTSE China A50 -0.1%\nSHANGHAI, May 28 (Reuters) - China shares ticked lower on Thursday, dragged down by losses in the healthcare sector as drugmakers retreated on concerns over a plunge in medicine prices.\n** The CSI300 index fell 0.2% to 5,137.37 points at the end of the morning session, while the Shanghai Composite Index lost 0.2% to 3,561.01 points.\n** Leading the declines, the CSI300 healthcare index slumped 2.6% by the midday break after price slumps were shown in the results of the fifth national government-backed drug bulk-buy program.\n** Hengrui , Guangzhou Kingmed Diagnostics Group Co Ltd , Asymchem Laboratories Tianjin Co Ltd, Bloomage Biotechnology Corp Ltd declined between 4.1% and 6.8%.\n** Average price cut was 56% among the 251 products for 61 types of medicines included in the list of preliminary bid winners, state news agency Xinhua said in a report.\n** Investors need to pay more attention to drugmakers' overall strength given a normalised bulk-buy mechanism, TF Securities said in a report, adding that bigger-than-expected price declines would be a risk for firms going forward.\n** China's monthly producer price index (PPI) is likely to rise 10% in June, piling pressure on downstream consumers, a senior official of China's banking and insurance watchdog told a forum in Beijing on Thursday.\n** On Wednesday, two Federal Reserve officials said a period of high inflation in the United States could last longer than anticipated, just a day after Fed Chair Jerome Powell played down rising price pressures.\n** The Biden administration ordered a ban on U.S. imports of a key solar panel material from Chinese-based Hoshine Silicon Industry Co over forced labour allegations, said two sources briefed on the matter.\n** Hoshine Silicon tumbled 9.9% after the U.S. ban.\n** The Hang Seng index added 0.1% to 28,838.96 points, while the Hong Kong China Enterprises Index gained 0.1%, to 10,679.86.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":128690712,"gmtCreate":1624512450436,"gmtModify":1703838929188,"author":{"id":"3572622102225035","authorId":"3572622102225035","name":"TheHaq","avatar":"https://static.tigerbbs.com/fa8f425ae08e71ad8583df23f2813d71","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":3,"crmLevelSwitch":0,"idStr":"3572622102225035","authorIdStr":"3572622102225035"},"htmlText":"Interesting outlook&nbsp;","listText":"Interesting outlook&nbsp;","text":"Interesting outlook","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/128690712","repostId":2145012162,"repostType":4,"repost":{"id":"2145012162","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1624509077,"share":"https://ttm.financial/m/news/2145012162?lang=&edition=fundamental","pubTime":"2021-06-24 12:31","market":"hk","language":"en","title":"China stocks slip as healthcare firms retreat; Hong Kong up","url":"https://stock-news.laohu8.com/highlight/detail?id=2145012162","media":"Reuters","summary":"* SSEC -0.2%, CSI300 -0.2%, HSI 0.1%\n* HK->Shanghai Connect daily quota used 4.4%, Shanghai->HK dail","content":"<p>* SSEC -0.2%, CSI300 -0.2%, HSI 0.1%</p>\n<p>* HK-&gt;Shanghai Connect daily quota used 4.4%, Shanghai-&gt;HK daily quota used 2.2%</p>\n<p>* FTSE China A50 -0.1%</p>\n<p>SHANGHAI, May 28 (Reuters) - China shares ticked lower on Thursday, dragged down by losses in the healthcare sector as drugmakers retreated on concerns over a plunge in medicine prices.</p>\n<p>** The CSI300 index fell 0.2% to 5,137.37 points at the end of the morning session, while the Shanghai Composite Index lost 0.2% to 3,561.01 points.</p>\n<p>** Leading the declines, the CSI300 healthcare index&nbsp;slumped 2.6% by the midday break after price slumps were shown in the results of the fifth national government-backed drug bulk-buy program.</p>\n<p>** Hengrui , Guangzhou Kingmed Diagnostics Group Co Ltd , Asymchem Laboratories Tianjin Co Ltd, Bloomage Biotechnology Corp Ltd declined between 4.1% and 6.8%.</p>\n<p>** Average price cut was 56% among the 251 products for 61 types of medicines included in the list of preliminary bid winners, state news agency Xinhua said in a report.</p>\n<p>** Investors need to pay more attention to drugmakers' overall strength given a normalised bulk-buy mechanism, TF Securities said in a report, adding that bigger-than-expected price declines would be a risk for firms going forward.</p>\n<p>** China's monthly producer price index (PPI) is likely to rise 10% in June, piling pressure on downstream consumers, a senior official of China's banking and insurance watchdog told a forum in Beijing on Thursday.</p>\n<p>** On Wednesday, two Federal Reserve officials said a period of high inflation in the United States could last longer than anticipated, just a day after Fed Chair Jerome Powell played down rising price pressures.</p>\n<p>** The Biden administration ordered a ban on U.S. imports of a key solar panel material from Chinese-based Hoshine Silicon Industry Co over forced labour allegations, said two sources briefed on the matter.</p>\n<p>** Hoshine Silicon tumbled 9.9% after the U.S. ban.</p>\n<p>** The Hang Seng index&nbsp;added 0.1% to 28,838.96 points, while the Hong Kong China Enterprises Index&nbsp;gained 0.1%, to 10,679.86.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China stocks slip as healthcare firms retreat; Hong Kong up</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina stocks slip as healthcare firms retreat; Hong Kong up\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-24 12:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* SSEC -0.2%, CSI300 -0.2%, HSI 0.1%</p>\n<p>* HK-&gt;Shanghai Connect daily quota used 4.4%, Shanghai-&gt;HK daily quota used 2.2%</p>\n<p>* FTSE China A50 -0.1%</p>\n<p>SHANGHAI, May 28 (Reuters) - China shares ticked lower on Thursday, dragged down by losses in the healthcare sector as drugmakers retreated on concerns over a plunge in medicine prices.</p>\n<p>** The CSI300 index fell 0.2% to 5,137.37 points at the end of the morning session, while the Shanghai Composite Index lost 0.2% to 3,561.01 points.</p>\n<p>** Leading the declines, the CSI300 healthcare index&nbsp;slumped 2.6% by the midday break after price slumps were shown in the results of the fifth national government-backed drug bulk-buy program.</p>\n<p>** Hengrui , Guangzhou Kingmed Diagnostics Group Co Ltd , Asymchem Laboratories Tianjin Co Ltd, Bloomage Biotechnology Corp Ltd declined between 4.1% and 6.8%.</p>\n<p>** Average price cut was 56% among the 251 products for 61 types of medicines included in the list of preliminary bid winners, state news agency Xinhua said in a report.</p>\n<p>** Investors need to pay more attention to drugmakers' overall strength given a normalised bulk-buy mechanism, TF Securities said in a report, adding that bigger-than-expected price declines would be a risk for firms going forward.</p>\n<p>** China's monthly producer price index (PPI) is likely to rise 10% in June, piling pressure on downstream consumers, a senior official of China's banking and insurance watchdog told a forum in Beijing on Thursday.</p>\n<p>** On Wednesday, two Federal Reserve officials said a period of high inflation in the United States could last longer than anticipated, just a day after Fed Chair Jerome Powell played down rising price pressures.</p>\n<p>** The Biden administration ordered a ban on U.S. imports of a key solar panel material from Chinese-based Hoshine Silicon Industry Co over forced labour allegations, said two sources briefed on the matter.</p>\n<p>** Hoshine Silicon tumbled 9.9% after the U.S. ban.</p>\n<p>** The Hang Seng index&nbsp;added 0.1% to 28,838.96 points, while the Hong Kong China Enterprises Index&nbsp;gained 0.1%, to 10,679.86.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"000001.SH":"上证指数","HSI":"恒生指数"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2145012162","content_text":"* SSEC -0.2%, CSI300 -0.2%, HSI 0.1%\n* HK->Shanghai Connect daily quota used 4.4%, Shanghai->HK daily quota used 2.2%\n* FTSE China A50 -0.1%\nSHANGHAI, May 28 (Reuters) - China shares ticked lower on Thursday, dragged down by losses in the healthcare sector as drugmakers retreated on concerns over a plunge in medicine prices.\n** The CSI300 index fell 0.2% to 5,137.37 points at the end of the morning session, while the Shanghai Composite Index lost 0.2% to 3,561.01 points.\n** Leading the declines, the CSI300 healthcare index slumped 2.6% by the midday break after price slumps were shown in the results of the fifth national government-backed drug bulk-buy program.\n** Hengrui , Guangzhou Kingmed Diagnostics Group Co Ltd , Asymchem Laboratories Tianjin Co Ltd, Bloomage Biotechnology Corp Ltd declined between 4.1% and 6.8%.\n** Average price cut was 56% among the 251 products for 61 types of medicines included in the list of preliminary bid winners, state news agency Xinhua said in a report.\n** Investors need to pay more attention to drugmakers' overall strength given a normalised bulk-buy mechanism, TF Securities said in a report, adding that bigger-than-expected price declines would be a risk for firms going forward.\n** China's monthly producer price index (PPI) is likely to rise 10% in June, piling pressure on downstream consumers, a senior official of China's banking and insurance watchdog told a forum in Beijing on Thursday.\n** On Wednesday, two Federal Reserve officials said a period of high inflation in the United States could last longer than anticipated, just a day after Fed Chair Jerome Powell played down rising price pressures.\n** The Biden administration ordered a ban on U.S. imports of a key solar panel material from Chinese-based Hoshine Silicon Industry Co over forced labour allegations, said two sources briefed on the matter.\n** Hoshine Silicon tumbled 9.9% after the U.S. ban.\n** The Hang Seng index added 0.1% to 28,838.96 points, while the Hong Kong China Enterprises Index gained 0.1%, to 10,679.86.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":128846629,"gmtCreate":1624511581761,"gmtModify":1703838893234,"author":{"id":"3576847817239184","authorId":"3576847817239184","name":"Bmaiw102","avatar":"https://static.itradeup.com/news/30a37cf03e98de0ed30b396e888c23e4","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3576847817239184","authorIdStr":"3576847817239184"},"htmlText":"Ouch&nbsp;","listText":"Ouch&nbsp;","text":"Ouch","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/128846629","repostId":2145012162,"repostType":4,"repost":{"id":"2145012162","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1624509077,"share":"https://ttm.financial/m/news/2145012162?lang=&edition=fundamental","pubTime":"2021-06-24 12:31","market":"hk","language":"en","title":"China stocks slip as healthcare firms retreat; Hong Kong up","url":"https://stock-news.laohu8.com/highlight/detail?id=2145012162","media":"Reuters","summary":"* SSEC -0.2%, CSI300 -0.2%, HSI 0.1%\n* HK->Shanghai Connect daily quota used 4.4%, Shanghai->HK dail","content":"<p>* SSEC -0.2%, CSI300 -0.2%, HSI 0.1%</p>\n<p>* HK-&gt;Shanghai Connect daily quota used 4.4%, Shanghai-&gt;HK daily quota used 2.2%</p>\n<p>* FTSE China A50 -0.1%</p>\n<p>SHANGHAI, May 28 (Reuters) - China shares ticked lower on Thursday, dragged down by losses in the healthcare sector as drugmakers retreated on concerns over a plunge in medicine prices.</p>\n<p>** The CSI300 index fell 0.2% to 5,137.37 points at the end of the morning session, while the Shanghai Composite Index lost 0.2% to 3,561.01 points.</p>\n<p>** Leading the declines, the CSI300 healthcare index&nbsp;slumped 2.6% by the midday break after price slumps were shown in the results of the fifth national government-backed drug bulk-buy program.</p>\n<p>** Hengrui , Guangzhou Kingmed Diagnostics Group Co Ltd , Asymchem Laboratories Tianjin Co Ltd, Bloomage Biotechnology Corp Ltd declined between 4.1% and 6.8%.</p>\n<p>** Average price cut was 56% among the 251 products for 61 types of medicines included in the list of preliminary bid winners, state news agency Xinhua said in a report.</p>\n<p>** Investors need to pay more attention to drugmakers' overall strength given a normalised bulk-buy mechanism, TF Securities said in a report, adding that bigger-than-expected price declines would be a risk for firms going forward.</p>\n<p>** China's monthly producer price index (PPI) is likely to rise 10% in June, piling pressure on downstream consumers, a senior official of China's banking and insurance watchdog told a forum in Beijing on Thursday.</p>\n<p>** On Wednesday, two Federal Reserve officials said a period of high inflation in the United States could last longer than anticipated, just a day after Fed Chair Jerome Powell played down rising price pressures.</p>\n<p>** The Biden administration ordered a ban on U.S. imports of a key solar panel material from Chinese-based Hoshine Silicon Industry Co over forced labour allegations, said two sources briefed on the matter.</p>\n<p>** Hoshine Silicon tumbled 9.9% after the U.S. ban.</p>\n<p>** The Hang Seng index&nbsp;added 0.1% to 28,838.96 points, while the Hong Kong China Enterprises Index&nbsp;gained 0.1%, to 10,679.86.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China stocks slip as healthcare firms retreat; Hong Kong up</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina stocks slip as healthcare firms retreat; Hong Kong up\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-24 12:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* SSEC -0.2%, CSI300 -0.2%, HSI 0.1%</p>\n<p>* HK-&gt;Shanghai Connect daily quota used 4.4%, Shanghai-&gt;HK daily quota used 2.2%</p>\n<p>* FTSE China A50 -0.1%</p>\n<p>SHANGHAI, May 28 (Reuters) - China shares ticked lower on Thursday, dragged down by losses in the healthcare sector as drugmakers retreated on concerns over a plunge in medicine prices.</p>\n<p>** The CSI300 index fell 0.2% to 5,137.37 points at the end of the morning session, while the Shanghai Composite Index lost 0.2% to 3,561.01 points.</p>\n<p>** Leading the declines, the CSI300 healthcare index&nbsp;slumped 2.6% by the midday break after price slumps were shown in the results of the fifth national government-backed drug bulk-buy program.</p>\n<p>** Hengrui , Guangzhou Kingmed Diagnostics Group Co Ltd , Asymchem Laboratories Tianjin Co Ltd, Bloomage Biotechnology Corp Ltd declined between 4.1% and 6.8%.</p>\n<p>** Average price cut was 56% among the 251 products for 61 types of medicines included in the list of preliminary bid winners, state news agency Xinhua said in a report.</p>\n<p>** Investors need to pay more attention to drugmakers' overall strength given a normalised bulk-buy mechanism, TF Securities said in a report, adding that bigger-than-expected price declines would be a risk for firms going forward.</p>\n<p>** China's monthly producer price index (PPI) is likely to rise 10% in June, piling pressure on downstream consumers, a senior official of China's banking and insurance watchdog told a forum in Beijing on Thursday.</p>\n<p>** On Wednesday, two Federal Reserve officials said a period of high inflation in the United States could last longer than anticipated, just a day after Fed Chair Jerome Powell played down rising price pressures.</p>\n<p>** The Biden administration ordered a ban on U.S. imports of a key solar panel material from Chinese-based Hoshine Silicon Industry Co over forced labour allegations, said two sources briefed on the matter.</p>\n<p>** Hoshine Silicon tumbled 9.9% after the U.S. ban.</p>\n<p>** The Hang Seng index&nbsp;added 0.1% to 28,838.96 points, while the Hong Kong China Enterprises Index&nbsp;gained 0.1%, to 10,679.86.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"000001.SH":"上证指数","HSI":"恒生指数"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2145012162","content_text":"* SSEC -0.2%, CSI300 -0.2%, HSI 0.1%\n* HK->Shanghai Connect daily quota used 4.4%, Shanghai->HK daily quota used 2.2%\n* FTSE China A50 -0.1%\nSHANGHAI, May 28 (Reuters) - China shares ticked lower on Thursday, dragged down by losses in the healthcare sector as drugmakers retreated on concerns over a plunge in medicine prices.\n** The CSI300 index fell 0.2% to 5,137.37 points at the end of the morning session, while the Shanghai Composite Index lost 0.2% to 3,561.01 points.\n** Leading the declines, the CSI300 healthcare index slumped 2.6% by the midday break after price slumps were shown in the results of the fifth national government-backed drug bulk-buy program.\n** Hengrui , Guangzhou Kingmed Diagnostics Group Co Ltd , Asymchem Laboratories Tianjin Co Ltd, Bloomage Biotechnology Corp Ltd declined between 4.1% and 6.8%.\n** Average price cut was 56% among the 251 products for 61 types of medicines included in the list of preliminary bid winners, state news agency Xinhua said in a report.\n** Investors need to pay more attention to drugmakers' overall strength given a normalised bulk-buy mechanism, TF Securities said in a report, adding that bigger-than-expected price declines would be a risk for firms going forward.\n** China's monthly producer price index (PPI) is likely to rise 10% in June, piling pressure on downstream consumers, a senior official of China's banking and insurance watchdog told a forum in Beijing on Thursday.\n** On Wednesday, two Federal Reserve officials said a period of high inflation in the United States could last longer than anticipated, just a day after Fed Chair Jerome Powell played down rising price pressures.\n** The Biden administration ordered a ban on U.S. imports of a key solar panel material from Chinese-based Hoshine Silicon Industry Co over forced labour allegations, said two sources briefed on the matter.\n** Hoshine Silicon tumbled 9.9% after the U.S. ban.\n** The Hang Seng index added 0.1% to 28,838.96 points, while the Hong Kong China Enterprises Index gained 0.1%, to 10,679.86.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":128846395,"gmtCreate":1624511571117,"gmtModify":1703838892908,"author":{"id":"3566524398877459","authorId":"3566524398877459","name":"angelA","avatar":"https://static.tigerbbs.com/e50185d396d432695a2f2d904ac22dda","vip":1,"crmLevel":6,"crmLevelSwitch":0,"idStr":"3566524398877459","authorIdStr":"3566524398877459"},"htmlText":"Like n comment pls","listText":"Like n comment pls","text":"Like n comment pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/128846395","repostId":2145012162,"repostType":4,"repost":{"id":"2145012162","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1624509077,"share":"https://ttm.financial/m/news/2145012162?lang=&edition=fundamental","pubTime":"2021-06-24 12:31","market":"hk","language":"en","title":"China stocks slip as healthcare firms retreat; Hong Kong up","url":"https://stock-news.laohu8.com/highlight/detail?id=2145012162","media":"Reuters","summary":"* SSEC -0.2%, CSI300 -0.2%, HSI 0.1%\n* HK->Shanghai Connect daily quota used 4.4%, Shanghai->HK dail","content":"<p>* SSEC -0.2%, CSI300 -0.2%, HSI 0.1%</p>\n<p>* HK-&gt;Shanghai Connect daily quota used 4.4%, Shanghai-&gt;HK daily quota used 2.2%</p>\n<p>* FTSE China A50 -0.1%</p>\n<p>SHANGHAI, May 28 (Reuters) - China shares ticked lower on Thursday, dragged down by losses in the healthcare sector as drugmakers retreated on concerns over a plunge in medicine prices.</p>\n<p>** The CSI300 index fell 0.2% to 5,137.37 points at the end of the morning session, while the Shanghai Composite Index lost 0.2% to 3,561.01 points.</p>\n<p>** Leading the declines, the CSI300 healthcare index&nbsp;slumped 2.6% by the midday break after price slumps were shown in the results of the fifth national government-backed drug bulk-buy program.</p>\n<p>** Hengrui , Guangzhou Kingmed Diagnostics Group Co Ltd , Asymchem Laboratories Tianjin Co Ltd, Bloomage Biotechnology Corp Ltd declined between 4.1% and 6.8%.</p>\n<p>** Average price cut was 56% among the 251 products for 61 types of medicines included in the list of preliminary bid winners, state news agency Xinhua said in a report.</p>\n<p>** Investors need to pay more attention to drugmakers' overall strength given a normalised bulk-buy mechanism, TF Securities said in a report, adding that bigger-than-expected price declines would be a risk for firms going forward.</p>\n<p>** China's monthly producer price index (PPI) is likely to rise 10% in June, piling pressure on downstream consumers, a senior official of China's banking and insurance watchdog told a forum in Beijing on Thursday.</p>\n<p>** On Wednesday, two Federal Reserve officials said a period of high inflation in the United States could last longer than anticipated, just a day after Fed Chair Jerome Powell played down rising price pressures.</p>\n<p>** The Biden administration ordered a ban on U.S. imports of a key solar panel material from Chinese-based Hoshine Silicon Industry Co over forced labour allegations, said two sources briefed on the matter.</p>\n<p>** Hoshine Silicon tumbled 9.9% after the U.S. ban.</p>\n<p>** The Hang Seng index&nbsp;added 0.1% to 28,838.96 points, while the Hong Kong China Enterprises Index&nbsp;gained 0.1%, to 10,679.86.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China stocks slip as healthcare firms retreat; Hong Kong up</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina stocks slip as healthcare firms retreat; Hong Kong up\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-24 12:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* SSEC -0.2%, CSI300 -0.2%, HSI 0.1%</p>\n<p>* HK-&gt;Shanghai Connect daily quota used 4.4%, Shanghai-&gt;HK daily quota used 2.2%</p>\n<p>* FTSE China A50 -0.1%</p>\n<p>SHANGHAI, May 28 (Reuters) - China shares ticked lower on Thursday, dragged down by losses in the healthcare sector as drugmakers retreated on concerns over a plunge in medicine prices.</p>\n<p>** The CSI300 index fell 0.2% to 5,137.37 points at the end of the morning session, while the Shanghai Composite Index lost 0.2% to 3,561.01 points.</p>\n<p>** Leading the declines, the CSI300 healthcare index&nbsp;slumped 2.6% by the midday break after price slumps were shown in the results of the fifth national government-backed drug bulk-buy program.</p>\n<p>** Hengrui , Guangzhou Kingmed Diagnostics Group Co Ltd , Asymchem Laboratories Tianjin Co Ltd, Bloomage Biotechnology Corp Ltd declined between 4.1% and 6.8%.</p>\n<p>** Average price cut was 56% among the 251 products for 61 types of medicines included in the list of preliminary bid winners, state news agency Xinhua said in a report.</p>\n<p>** Investors need to pay more attention to drugmakers' overall strength given a normalised bulk-buy mechanism, TF Securities said in a report, adding that bigger-than-expected price declines would be a risk for firms going forward.</p>\n<p>** China's monthly producer price index (PPI) is likely to rise 10% in June, piling pressure on downstream consumers, a senior official of China's banking and insurance watchdog told a forum in Beijing on Thursday.</p>\n<p>** On Wednesday, two Federal Reserve officials said a period of high inflation in the United States could last longer than anticipated, just a day after Fed Chair Jerome Powell played down rising price pressures.</p>\n<p>** The Biden administration ordered a ban on U.S. imports of a key solar panel material from Chinese-based Hoshine Silicon Industry Co over forced labour allegations, said two sources briefed on the matter.</p>\n<p>** Hoshine Silicon tumbled 9.9% after the U.S. ban.</p>\n<p>** The Hang Seng index&nbsp;added 0.1% to 28,838.96 points, while the Hong Kong China Enterprises Index&nbsp;gained 0.1%, to 10,679.86.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"000001.SH":"上证指数","HSI":"恒生指数"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2145012162","content_text":"* SSEC -0.2%, CSI300 -0.2%, HSI 0.1%\n* HK->Shanghai Connect daily quota used 4.4%, Shanghai->HK daily quota used 2.2%\n* FTSE China A50 -0.1%\nSHANGHAI, May 28 (Reuters) - China shares ticked lower on Thursday, dragged down by losses in the healthcare sector as drugmakers retreated on concerns over a plunge in medicine prices.\n** The CSI300 index fell 0.2% to 5,137.37 points at the end of the morning session, while the Shanghai Composite Index lost 0.2% to 3,561.01 points.\n** Leading the declines, the CSI300 healthcare index slumped 2.6% by the midday break after price slumps were shown in the results of the fifth national government-backed drug bulk-buy program.\n** Hengrui , Guangzhou Kingmed Diagnostics Group Co Ltd , Asymchem Laboratories Tianjin Co Ltd, Bloomage Biotechnology Corp Ltd declined between 4.1% and 6.8%.\n** Average price cut was 56% among the 251 products for 61 types of medicines included in the list of preliminary bid winners, state news agency Xinhua said in a report.\n** Investors need to pay more attention to drugmakers' overall strength given a normalised bulk-buy mechanism, TF Securities said in a report, adding that bigger-than-expected price declines would be a risk for firms going forward.\n** China's monthly producer price index (PPI) is likely to rise 10% in June, piling pressure on downstream consumers, a senior official of China's banking and insurance watchdog told a forum in Beijing on Thursday.\n** On Wednesday, two Federal Reserve officials said a period of high inflation in the United States could last longer than anticipated, just a day after Fed Chair Jerome Powell played down rising price pressures.\n** The Biden administration ordered a ban on U.S. imports of a key solar panel material from Chinese-based Hoshine Silicon Industry Co over forced labour allegations, said two sources briefed on the matter.\n** Hoshine Silicon tumbled 9.9% after the U.S. ban.\n** The Hang Seng index added 0.1% to 28,838.96 points, while the Hong Kong China Enterprises Index gained 0.1%, to 10,679.86.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4990194,"gmtCreate":1624511663535,"gmtModify":1663229888637,"authorId":3555884467896100,"author":{"id":3555884467896100,"idStr":"3555884467896100","authorId":3555884467896100,"name":"sleepymoon","avatar":"https://static.tigerbbs.com/017d47c34167b5c3d7accfb69274dd36","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":128846395,"type":1,"supId":0,"prevId":0,"content":"<u>Can</u>","text":"<u>Can</u>","html":"<u>Can</u>"},{"id":4990565,"gmtCreate":1624513172273,"gmtModify":1663229888240,"authorId":4087557719105110,"author":{"id":4087557719105110,"idStr":"4087557719105110","authorId":4087557719105110,"name":"csyen","avatar":"https://community-static.tradeup.com/news/ed7eb4ecb1a7bd9e941d5aba9b858546","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":128846395,"type":1,"supId":0,"prevId":0,"content":"<u>can</u>","text":"<u>can</u>","html":"<u>can</u>"}],"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":40,"commentSize":6,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2145012162"}